These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 22183770)

  • 1. Wallerian degeneration slow mouse neurons are protected against cell death caused by mechanisms involving mitochondrial electron transport dysfunction.
    Tokunaga S; Araki T
    J Neurosci Res; 2012 Mar; 90(3):664-71. PubMed ID: 22183770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Degeneration of neuronal cell bodies following axonal injury in Wld(S) mice.
    Wang AL; Yuan M; Neufeld AH
    J Neurosci Res; 2006 Dec; 84(8):1799-807. PubMed ID: 17022038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The slow Wallerian degeneration gene in vivo protects motor axons but not their cell bodies after avulsion and neonatal axotomy.
    Adalbert R; Nógrádi A; Szabó A; Coleman MP
    Eur J Neurosci; 2006 Oct; 24(8):2163-8. PubMed ID: 17074042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WldS can delay Wallerian degeneration in mice when interaction with valosin-containing protein is weakened.
    Beirowski B; Morreale G; Conforti L; Mazzola F; Di Stefano M; Wilbrey A; Babetto E; Janeckova L; Magni G; Coleman MP
    Neuroscience; 2010 Mar; 166(1):201-11. PubMed ID: 20018231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nicotinamide mononucleotide adenylyltransferase expression in mitochondrial matrix delays Wallerian degeneration.
    Yahata N; Yuasa S; Araki T
    J Neurosci; 2009 May; 29(19):6276-84. PubMed ID: 19439605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prion disease development in slow Wallerian degeneration (Wld(S)) mice.
    Gültner S; Laue M; Riemer C; Heise I; Baier M
    Neurosci Lett; 2009 Jun; 456(2):93-8. PubMed ID: 19429141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The gene for slow Wallerian degeneration (Wld(s)) is also protective against vincristine neuropathy.
    Wang M; Wu Y; Culver DG; Glass JD
    Neurobiol Dis; 2001 Feb; 8(1):155-61. PubMed ID: 11162249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NAD(+) and axon degeneration revisited: Nmnat1 cannot substitute for Wld(S) to delay Wallerian degeneration.
    Conforti L; Fang G; Beirowski B; Wang MS; Sorci L; Asress S; Adalbert R; Silva A; Bridge K; Huang XP; Magni G; Glass JD; Coleman MP
    Cell Death Differ; 2007 Jan; 14(1):116-27. PubMed ID: 16645633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Axon degeneration: Mechanisms and implications of a distinct program from cell death.
    Yan T; Feng Y; Zhai Q
    Neurochem Int; 2010 Mar; 56(4):529-34. PubMed ID: 20117162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The slow Wallerian degeneration gene, WldS, inhibits axonal spheroid pathology in gracile axonal dystrophy mice.
    Mi W; Beirowski B; Gillingwater TH; Adalbert R; Wagner D; Grumme D; Osaka H; Conforti L; Arnhold S; Addicks K; Wada K; Ribchester RR; Coleman MP
    Brain; 2005 Feb; 128(Pt 2):405-16. PubMed ID: 15644421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the neuroprotective slow Wallerian degeneration (WldS) gene in non-neuronal tissues.
    Wishart TM; Brownstein DG; Thomson D; Tabakova AM; Boothe KM; Tsao JW; Gillingwater TH
    BMC Neurosci; 2009 Dec; 10():148. PubMed ID: 20015399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Axotomy-dependent and -independent synapse elimination in organ cultures of Wld(s) mutant mouse skeletal muscle.
    Parson SH; Ribchester RR; Davie N; Gandhi NP; Malik RQ; Gillingwater TH; Thomson D
    J Neurosci Res; 2004 Apr; 76(1):64-75. PubMed ID: 15048930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Axon degeneration mechanisms: commonality amid diversity.
    Coleman M
    Nat Rev Neurosci; 2005 Nov; 6(11):889-98. PubMed ID: 16224497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a critical site in Wld(s): essential for Nmnat enzyme activity and axon-protective function.
    Jia H; Yan T; Feng Y; Zeng C; Shi X; Zhai Q
    Neurosci Lett; 2007 Feb; 413(1):46-51. PubMed ID: 17207927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Over-expression of alpha-synuclein in the nervous system enhances axonal degeneration after peripheral nerve lesion in a transgenic mouse strain.
    Siebert H; Kahle PJ; Kramer ML; Isik T; Schlüter OM; Schulz-Schaeffer WJ; Brück W
    J Neurochem; 2010 Aug; 114(4):1007-18. PubMed ID: 20524960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mammalian Sir2-related protein (SIRT) 2-mediated modulation of resistance to axonal degeneration in slow Wallerian degeneration mice: a crucial role of tubulin deacetylation.
    Suzuki K; Koike T
    Neuroscience; 2007 Jul; 147(3):599-612. PubMed ID: 17574768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential proteomics analysis of synaptic proteins identifies potential cellular targets and protein mediators of synaptic neuroprotection conferred by the slow Wallerian degeneration (Wlds) gene.
    Wishart TM; Paterson JM; Short DM; Meredith S; Robertson KA; Sutherland C; Cousin MA; Dutia MB; Gillingwater TH
    Mol Cell Proteomics; 2007 Aug; 6(8):1318-30. PubMed ID: 17470424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A rat model of slow Wallerian degeneration (WldS) with improved preservation of neuromuscular synapses.
    Adalbert R; Gillingwater TH; Haley JE; Bridge K; Beirowski B; Berek L; Wagner D; Grumme D; Thomson D; Celik A; Addicks K; Ribchester RR; Coleman MP
    Eur J Neurosci; 2005 Jan; 21(1):271-7. PubMed ID: 15654865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reducing expression of NAD+ synthesizing enzyme NMNAT1 does not affect the rate of Wallerian degeneration.
    Conforti L; Janeckova L; Wagner D; Mazzola F; Cialabrini L; Di Stefano M; Orsomando G; Magni G; Bendotti C; Smyth N; Coleman M
    FEBS J; 2011 Aug; 278(15):2666-79. PubMed ID: 21615689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WldS prevents axon degeneration through increased mitochondrial flux and enhanced mitochondrial Ca2+ buffering.
    Avery MA; Rooney TM; Pandya JD; Wishart TM; Gillingwater TH; Geddes JW; Sullivan PG; Freeman MR
    Curr Biol; 2012 Apr; 22(7):596-600. PubMed ID: 22425157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.